Endovascular Stent Grafts Market Report 2025

This endovascular stent grafts market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The endovascular stent grafts market size has grown exponentially in recent years. It will grow from $1.05 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 37.8%. The growth in the historic period can be attributed to rise in the incidence of aortic aneurysms, rising aging population, increasing healthcare spending in developed regions, rise in number of ambulatory surgical centers, and rising incidence of chronic disease.

The endovascular stent grafts market size is expected to see exponential growth in the next few years. It will grow to $5.19 billion in 2029 at a compound annual growth rate (CAGR) of 37.6%. The growth in the forecast period can be attributed to ongoing shift towards minimally invasive procedures, increase in vascular diseases such as atherosclerosis, and pulmonary embolism, favorable reimbursement policies, increase in number of hospitals, and increasing diabetes even in the young generation. Major trends in the forecast period include integrating artificial intelligence, innovating advanced imaging technologies, developing of patient-specific or customizable stent grafts, developing of next-generation tissue-engineered vascular grafts, and technology advancements.

The rising prevalence of cardiovascular diseases is expected to boost the growth of the endovascular stent graft market in the future. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart and blood vessels. The increasing incidence of these diseases is attributed to various factors, including lifestyle choices, medical conditions, genetic predispositions, and environmental influences. Endovascular stent grafts provide an effective treatment option for cardiovascular diseases by focusing on minimizing invasiveness and enhancing patient outcomes. These stent grafts reinforce weakened vessel walls, preventing ruptures and lowering the risk of life-threatening complications. For example, in December 2023, data from the Australian Institute of Health and Welfare, an Australian government agency, revealed that the number of doctor-certified deaths due to coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing prevalence of cardiovascular diseases is driving the growth of the endovascular stent graft market.

Major companies in the endovascular stent graft market are concentrating on developing innovative products, such as thoracic aortic stent-grafts, to improve the precision and effectiveness of treating thoracic aortic aneurysms and dissections. These advancements aim to enhance patient outcomes and address complex anatomical challenges through advanced technology and design enhancements. A thoracic aortic stent graft is a specialized device used in endovascular surgery to manage diseases of the thoracic aorta, which is the section of the aorta located in the chest. It provides a combination of safety, efficacy, and convenience for treating thoracic aortic conditions. For example, in February 2024, Endovastec, a China-based medical device company, launched the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and carried out its first clinical application in Switzerland. The Hector system marks a significant step forward in endovascular stent graft technology, featuring a multi-branch design that allows for the treatment of complex thoracic aortic conditions by preserving and accommodating essential aortic branches, including those supplying vital organs.

In August 2022, W. L. Gore & Associates Inc. (Gore), a US-based company specializing in a variety of medical devices, acquired InnAVasc Medical Inc. for an undisclosed sum. This acquisition was strategically intended to strengthen Gore's position in the vascular sector by incorporating InnAVasc's advanced endovascular technologies. InnAVasc Medical Inc., also a US-based firm, is known for its production of endovascular stent grafts.

Major companies operating in the endovascular stent grafts market are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Terumo Corporation, Getinge AB, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc.

North America was the largest region in the endovascular stent grafts market in 2024. The regions covered in the endovascular stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endovascular stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Endovascular stent grafts are medical devices used to address conditions affecting blood vessels, such as aneurysms or stenosis. They comprise a metal stent a small mesh tube covered with a fabric graft. The stent graft is introduced into the affected blood vessel via a catheter, usually inserted into a large artery in the groin or arm. These devices frequently repair aneurysms (enlarged sections of blood vessels) or other vessel damage, providing a less invasive alternative to traditional surgery.

The primary types of endovascular stent grafts include hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aorta diseases, and peripheral vascular grafts. Hemodialysis access grafts are specifically designed to provide an access point for hemodialysis in patients with kidney failure. Various materials, including synthetic, biological, and hybrid vascular grafts, are utilized in different applications such as cardiac aneurysms, kidney failure, vascular occlusion, and coronary artery diseases.

The endovascular stent grafts market research report is one of a series of new reports that provides endovascular stent grafts market statistics, including endovascular stent grafts industry global market size, regional shares, competitors with an endovascular stent grafts market share, detailed endovascular stent grafts market segments, market trends, and opportunities, and any further data you may need to thrive in the endovascular stent grafts industry. This endovascular stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endovascular stent grafts market consists of sales of aortoiliac stent grafts, thoracic endograft, and abdominal endografts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.